🚀 VC round data is live in beta, check it out!
Predict Overview
About Predict
Predict SpA develops innovative healthcare technologies, such as Optip and Mistral, and sells medical diagnostic imaging systems. Its products include Versana Active GE, Optic probe, Versana Balance GE, Voluson S-series, and Vivid T8.
Founded
N/A
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$7M
Predict Financials
Predict reported last fiscal year revenue of $8M and EBITDA of $959K.
In the same fiscal year, Predict generated $3M in gross profit, $959K in EBITDA, and $395K in net income.
Predict P&L
In the most recent fiscal year, Predict reported revenue of $8M and EBITDA of $959K.
Predict expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $8M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $3M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 41% | XXX | XXX | XXX |
| EBITDA | — | XXX | $959K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 8% | XXX | XXX | XXX |
| Net Profit | — | XXX | $395K | XXX | XXX | XXX |
| Net Margin | — | XXX | 5% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Predict Stock Performance
Predict has current market cap of $7M, and enterprise value of $7M.
Market Cap Evolution
Predict's stock price is $0.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $7M | 0.0% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPredict Valuation Multiples
Predict trades at 0.8x EV/Revenue multiple, and 7.0x EV/EBITDA.
Predict Financial Valuation Multiples
As of April 20, 2026, Predict has market cap of $7M and EV of $7M.
Equity research analysts estimate Predict's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Predict has a P/E ratio of 17.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 7.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 10.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.0x | XXX | XXX | XXX |
| P/E | — | XXX | 17.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (9.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Predict Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Predict Margins & Growth Rates
Predict's revenue in the last fiscal year declined by (7%).
Predict Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Predict Public Comps
See public comps and valuation multiples for other Medical Devices comps.
Valuation data powered by FactSet, Inc.
Predict M&A Activity
Predict acquired XXX companies to date.
Last acquisition by Predict was on XXXXXXXX, XXXXX. Predict acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Predict
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPredict Investment Activity
Predict invested in XXX companies to date.
Predict made its latest investment on XXXXXXXX, XXXXX. Predict invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Predict
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Predict
| Where is Predict headquartered? | Predict is headquartered in Italy. |
| Is Predict publicly listed? | Yes, Predict is a public company listed on Borsa Italiana. |
| What is the stock symbol of Predict? | Predict trades under PRE ticker. |
| When did Predict go public? | Predict went public in 2024. |
| Who are competitors of Predict? | Predict main competitors are Iconovo, Lucyd, Carmat, Bio-Gate. |
| What is the current market cap of Predict? | Predict's current market cap is $7M. |
| What is the current revenue of Predict? | Predict's last fiscal year revenue is $8M. |
| What is the current EV/Revenue multiple of Predict? | Current revenue multiple of Predict is 0.8x. |
| Is Predict profitable? | No, Predict is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.